Perry Robins, MD, is the Editor-in-Chief of the Journal of Drugs in Dermatology. He was the Professor Emeritus of Dermatology at the New York University School of Medicine. Dr. Robins practiced medicine for over 40 years and has treated more than 47,000 skin cancer patients. Over 40% of the doctors who specialize in skin cancer were either trained by Dr. Robins himself or by doctors he has trained. He has lectured in 37 countries in 4 languages. He performed more than 500 procedures annually and conducted training workshops for his peers on advanced techniques of dermatologic surgery.

Dr. Robins is the founder and past President of The Skin Cancer Foundation, a national organization dedicated to the research of skin cancer and public and medical education. Dr. Robins was also the founder/president of the International Society of Dermatologic Surgeons, founder/former-president of the Mohs Society, and former-president of the American Society of Dermatologic Surgery.